首页 | 本学科首页   官方微博 | 高级检索  
检索        

雷公藤治疗类风湿性关节炎研究进展
引用本文:白雪,付瑞嘉,乐世俊,陈艳琰,徐顶巧,唐于平,段金廒.雷公藤治疗类风湿性关节炎研究进展[J].中草药,2020,51(1):265-275.
作者姓名:白雪  付瑞嘉  乐世俊  陈艳琰  徐顶巧  唐于平  段金廒
作者单位:陕西中医药大学 陕西省中医药管理局中药配伍重点研究室, 陕西西安 712046,陕西中医药大学 陕西省中医药管理局中药配伍重点研究室, 陕西西安 712046,陕西中医药大学 陕西省中医药管理局中药配伍重点研究室, 陕西西安 712046,陕西中医药大学 陕西省中医药管理局中药配伍重点研究室, 陕西西安 712046,陕西中医药大学 陕西省中医药管理局中药配伍重点研究室, 陕西西安 712046,陕西中医药大学 陕西省中医药管理局中药配伍重点研究室, 陕西西安 712046,南京中医药大学 江苏省中药资源产业化过程协同创新中心, 江苏南京 210023
基金项目:国家重点研发计划课题(2019YFC1711003);陕西中医药大学校级科研课题研究生创新项目(2020年度);陕西中医药大学学科创新团队项目(2019-YL10)
摘    要:类风湿关节炎(RA)是一种以滑膜持续炎症和关节软骨及骨质破坏为特征的慢性自身免疫性疾病,随着人口老龄化不断加剧,RA的发病率逐年升高,公共卫生负担日趋严重。雷公藤具有祛风通络、除湿止痛、解毒杀虫的功效,临床常用于治疗多种自身免疫性疾病、肿瘤及皮肤病等,尤其在治疗RA方面疗效显著。从实验药理学与临床研究2个方面系统综述近年来雷公藤治疗RA的最新研究进展,包括雷公藤单味药应用、雷公藤与其他中药配伍应用以及雷公藤与化学药联合用药,以期促进雷公藤用于RA治疗的创新药物研发与临床合理有效应用。

关 键 词:雷公藤  类风湿性关节炎  配伍  增效  减毒
收稿时间:2019/10/16 0:00:00

Research progress of Tripterygium wilfordii in treatment of rheumatoid arthritis
BAI Xue,FU Rui-ji,YUE Shi-jun,CHEN Yan-yan,XU Ding-qiao,TANG Yu-ping and DUAN Jin-ao.Research progress of Tripterygium wilfordii in treatment of rheumatoid arthritis[J].Chinese Traditional and Herbal Drugs,2020,51(1):265-275.
Authors:BAI Xue  FU Rui-ji  YUE Shi-jun  CHEN Yan-yan  XU Ding-qiao  TANG Yu-ping and DUAN Jin-ao
Institution:Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xi''an 712046, China,Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xi''an 712046, China,Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xi''an 712046, China,Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xi''an 712046, China,Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xi''an 712046, China,Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xi''an 712046, China and Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China
Abstract:Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovitis and destruction of articular cartilage and bone. With the aging of the population, the incidence of RA is increasing year by year and the burden of public health is becoming more and more serious. Tripterygium wilfordii has the effects of dispelling wind and dredging collaterals, dehumidifying and relieving pain, detoxification and insecticide. It is often used in the treatment of various autoimmune diseases, tumors and skin diseases in clinic, and the prominent effect is observed in the treatment of RA especially. This review systematically summarizes and discusses the latest research progress of T. wilfordii in the treatment of RA in the aspects of experimental pharmacology and clinical research, including its single application, the compatible application with other Chinese materia medica, and the combination of Western medicine, which is expected to promote the innovative drug development and more reasonable and effective clinical application of T. wilfordii in the treatment of RA.
Keywords:Tripterygium wilfordii Hook  f    rheumatoid arthritis  compatibility  synergism  detoxification
本文献已被 CNKI 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号